Morgan Stanley analyst Tejas Savant maintained a Buy rating on 10x Genomics (TXG – Research Report) today and set a price target of $26.00. The ...

Revenues up 115% year-over-year to a record $1.01 billion.Q4 Net Deposits grow to a record $16 billion.Q4 Gold Subscribers up 86% ...

If you’re ready to make a way-too-early prediction about who will play in the Super Bowl next year based on the logo’s colors ...

The logo that year had two main colors ... NEW ORLEANS, LOUISIANA – FEBRUARY 10: The Super Bowl LX logo is unveiled as NFL Commissioner Roger Goodell speaks during the Host Committee Handoff ...

Genomics reported a Q4 EPS loss of $(0.40), missing estimates, while revenue declined 10% year over year. Analysts lowered price targets amid profitability concerns.

Finding stocks with the potential to double in just three years is no easy feat, even in this bull market. Plenty of ...

CEO Serge Saxonov highlighted strong growth across platforms, with total revenue for Q4 2023 reaching $184 million, an 18% increase year-over-year. Spatial products contributed significantly, with ...

The cost of using any given level of artificial intelligence falls by approximately ten-fold every year and could lead to ... a given level of AI falls about 10x every 12 months, and lower prices ...

The company reported $261 million in revenue and adjusted earnings of $0.09 per share, slightly above analysts' consensus ...

Plastic Odyssey is a global initiative dedicated to tackling plastic pollution in the world's most affected regions. Over the ...